Evidence map›Paper›PMID 31663201›Full record

ArticleJournal of mass spectrometry : JMS2020

Mass spectrometry and planetary exploration: A brief review and future projection.

Ricardo Arevalo, Ziqin Ni, Ryan M Danell

Abstract read
In one paragraph

Article in Journal of mass spectrometry : JMS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. IMA fungus · 2025
    Review
  6. Review
  7. Alfred Otto Carl Nier: On the Shoulders of a Mass Spectrometry Giant.Journal of the American Society for Mass Spectrometry · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Metabolomic Profile of the FungusFrontiers in microbiology · 2022
    Article
  17. New "Omics" Approaches as Tools to Explore Mechanistic Nanotoxicology.Advances in experimental medicine and biology · 2022
    Article
  18. Article
  19. Clinical Chemistry for Developing Countries: Mass Spectrometry.Annual review of analytical chemistry (Palo Alto, Calif.) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ricardo ArevaloDepartment of Geology, University of Maryland, College Park, Maryland.ORCID https://orcid.org/0000-0002-0558-5090
Ziqin NiDepartment of Geology, University of Maryland, College Park, Maryland.ORCID https://orcid.org/0000-0003-2616-1630
Ryan M DanellDanell Consulting, Inc, Winterville, North Carolina.ORCID https://orcid.org/0000-0003-4863-1998

Funding

NASA 80NSSC18K0932NASA 80NSSC19K0610
6 · The paper itself

Abstract

Since the inception of mass spectrometry more than a century ago, the field has matured as analytical capabilities have progressed, instrument configurations multiplied, and applications proliferated. Modern systems are able to characterize volatile and nonvolatile sample materials, quantitatively measure abundances of molecular and elemental species with low limits of detection, and determine isotopic compositions with high degrees of precision and accuracy. Consequently, mass spectrometers have a rich history and promising future in planetary exploration. Here, we provide a short review on the development of mass analyzers and supporting subsystems (eg, ionization sources and detector assemblies) that have significant heritage in spaceflight applications, and we introduce a selection of emerging technologies that may enable new and/or augmented mission concepts in the coming decades.

Indexed as

ion trapmass analyzerOrbitrapquadrupolesector fieldspaceflightspectrometrytime-of-flight

Identifiers

PMID31663201
PMCPMC7050511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.